Identifying predictors of racial disparity in treatment and mortality among patients diagnosed with breast cancer in South Carolina and geospatial investigation of breast cancer patient navigation

确定南卡罗来纳州乳腺癌患者治疗和死亡率种族差异的预测因素以及乳腺癌患者导航的地理空间调查

基本信息

项目摘要

Delay in treatment initiation contributes to higher mortality among Black women despite lower incidence of breast cancer (BrCa) among Black compared to White women. Survival studies show that a delay of two months has been linked with a less favorable survival among BrCa cases. The use of Adjuvant Hormonal Therapy (AHT) has been shown to improve both short- and long-term survival among Hormone Receptor Positive (HR+) BrCa patients worldwide as it reduces BrCa mortality and reoccurrence. The advantages of AHT notwithstanding, 10-30% of eligible BrCa patients never start treatment with AHT and many who start AHT never complete the treatment leading to reoccurrence and increased mortality. This lack of initial uptake and adherence to AHT is worse among Blacks compared to Whites. Effective reduction of disparities in treatment delays and mortality among racial minorities will require the identification of the mechanisms by which disparities occur particularly, studying neighborhood-level factors that have been shown to affect the odds of receipt of BrCa treatments among Black women. For this application, I propose to assess racial disparities in BrCa treatment and mortality in South Carolina (SC) utilizing data that was derived from all female BrCa cases over eight years from the SC Central Cancer Registry linked with administrative medical and pharmacy claims data for both publicly insured and privately insured BrCa patients. I will assess the complex interplay between 1) geographic factors, 2) racial disparities 3) Geographical Information System (GIS) mapping, 4) survival methods and 5) multi-level models to identify predictors of treatment delays and mortality that can be intervened upon. GIS methods have not been utilized to specifically identify individual- and neighborhood-level characteristics that may contribute to BrCa mortality among blacks within the context of multilevel survival modelling; this has the potential to allow for the application of evidence-based approaches to reduce disparities. This project has 3 aims: 1) to assess racial disparities in treatment delays and the utilization of AHT among patients diagnosed with breast cancer (Pre-Doctoral and completed); 2) to identify predictors of dissimilarity in breast cancer related survival by health regions among Black women in SC utilizing multilevel survival models and GIS methodologies (Pre-Doctoral and yet to be completed); 3) to assess if neighborhood-level factors modify the effect of patient navigation on uptake of initial recommended breast cancer care and time to diagnostic resolution among minority populations (Post-Doctoral direction). The F99 phase of this fellowship award will provide the necessary training and mentoring to further my knowledge and skill in 1) disparities, 2) survival, 3) multi-level, 4) GIS, and 5) geospatial analyses. The K00 phase will expose me to 1) interventional analyses such as cancer patient navigation, 2) Randomized Controlled Trials and 3) enhance my scholarly productivity and professional development during this fellowship, including preparation and submission of grants and publications.
尽管发病率较低,但延迟开始治疗导致黑人妇女死亡率较高

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Oluwole Adeyemi Babatunde其他文献

Oluwole Adeyemi Babatunde的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Oluwole Adeyemi Babatunde', 18)}}的其他基金

Identifying predictors of racial disparity in treatment and mortality among patients diagnosed with breast cancer in South Carolina and geospatial investigation of breast cancer patient navigation
确定南卡罗来纳州乳腺癌患者治疗和死亡率种族差异的预测因素以及乳腺癌患者导航的地理空间调查
  • 批准号:
    9978735
  • 财政年份:
    2019
  • 资助金额:
    $ 4.07万
  • 项目类别:
Identifying predictors of racial disparity in treatment and mortality among patients diagnosed with breast cancer in South Carolina and geospatial investigation of breast cancer patient navigation
确定南卡罗来纳州乳腺癌患者治疗和死亡率种族差异的预测因素以及乳腺癌患者导航的地理空间调查
  • 批准号:
    9567963
  • 财政年份:
    2017
  • 资助金额:
    $ 4.07万
  • 项目类别:

相似海外基金

Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
  • 批准号:
    23K08213
  • 财政年份:
    2023
  • 资助金额:
    $ 4.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
  • 批准号:
    2881726
  • 财政年份:
    2023
  • 资助金额:
    $ 4.07万
  • 项目类别:
    Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
  • 批准号:
    10735090
  • 财政年份:
    2023
  • 资助金额:
    $ 4.07万
  • 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
  • 批准号:
    10722146
  • 财政年份:
    2023
  • 资助金额:
    $ 4.07万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 4.07万
  • 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
  • 批准号:
    10935776
  • 财政年份:
    2023
  • 资助金额:
    $ 4.07万
  • 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
  • 批准号:
    10935796
  • 财政年份:
    2023
  • 资助金额:
    $ 4.07万
  • 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
  • 批准号:
    10935775
  • 财政年份:
    2023
  • 资助金额:
    $ 4.07万
  • 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
  • 批准号:
    10735964
  • 财政年份:
    2023
  • 资助金额:
    $ 4.07万
  • 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
  • 批准号:
    10649041
  • 财政年份:
    2023
  • 资助金额:
    $ 4.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了